Stockscreener 앱 받기
20.06
2.67%
-0.55
Dianthus Therapeutics Inc 주식(DNTH)의 최신 뉴스
Dianthus Therapeutics (NASDAQ:DNTH) Stock Price Down 4.9%Should You Sell? - MarketBeat
Dianthus Therapeutics (NASDAQ:DNTH) Shares Up 8.4%Should You Buy? - MarketBeat
DNTH’s Stock Market Adventure: -16.38% YTD Growth Amidst Volatility - investchronicle.com
What is William Blair's Estimate for DNTH FY2025 Earnings? - MarketBeat
William Blair Begins Coverage on Dianthus Therapeutics (NASDAQ:DNTH) - MarketBeat
FY2025 Earnings Estimate for DNTH Issued By William Blair - Defense World
Dianthus Therapeutics (NASDAQ:DNTH) Coverage Initiated at William Blair - Defense World
Dianthus Therapeutics stock rises after William Blair initiates coverage By Investing.com - Investing.com Canada
William Blair Initiates Dianthus Therapeutics at Outperform - MarketScreener
What is Lifesci Capital’s Estimate for DNTH Q2 Earnings? - Defense World
Stifel Reaffirms Buy on Dianthus Therapeutics, Inc. (DNTH) with 186% Upside - MSN
Buy Rating for Dianthus Therapeutics: Promising Growth Potential of DNTH103 in Neuromuscular Disease Treatment - TipRanks
Equities Analysts Issue Forecasts for DNTH FY2026 Earnings - MarketBeat
Dianthus Therapeutics (NASDAQ:DNTH) Trading Down 4.6%What's Next? - MarketBeat
California State Teachers Retirement System Sells 1,352 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World
Two Sigma Investments LP Sells 588 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World
Squarepoint Ops LLC Has $242,000 Stock Holdings in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World
Millennium Management LLC Has $1.97 Million Holdings in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat
Bank of America Corp DE Sells 9,858 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Acquired by Millennium Management LLC - Defense World
BNP Paribas Financial Markets Makes New Investment in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World
Dianthus Therapeutics (NASDAQ:DNTH) Shares Down 5.2%Time to Sell? - MarketBeat
Analysts Set Dianthus Therapeutics, Inc. (NASDAQ:DNTH) PT at $53.00 - MarketBeat
Deutsche Bank AG Increases Holdings in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World
Dianthus Therapeutics to Webcast Presentation at the Jefferies Global Healthcare Conference - The Manila Times
Autoimmune Disease Biotech Dianthus Therapeutics CEO Takes Stage at Major Jefferies Conference - Stock Titan
Northern Trust Corp Acquires 42,923 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Purchased by Woodline Partners LP - MarketBeat
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Receives Average Recommendation of “Buy” from Brokerages - Defense World
Point72 Asset Management L.P. Reduces Stock Holdings in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Acquired by Vestal Point Capital LP - MarketBeat
Dianthus Therapeutics appoints new board member By Investing.com - Investing.com India
Dianthus Therapeutics Appoints Simon Read, Ph.D., to Board of Directors - citybiz
Dianthus Therapeutics appoints new board member - Investing.com Australia
Dianthus Therapeutics Announces Board Changes and Elections - TipRanks
Former Novartis-Acquired CEO Joins Dianthus Board Ahead of Critical Phase 2 Data - Stock Titan
Janus Henderson Group PLC Buys 136,314 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat
Buy Rating Affirmed for Dianthus Therapeutics: Promising Clinical Potential of DNTH103 in CIDP Treatment - TipRanks
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Position Raised by Octagon Capital Advisors LP - MarketBeat
Robert W. Baird Has Lowered Expectations for Dianthus Therapeutics (NASDAQ:DNTH) Stock Price - MarketBeat
FY2025 EPS Estimates for DNTH Lowered by Cantor Fitzgerald - Defense World
Dianthus Therapeutics (NASDAQ:DNTH) Earns "Buy" Rating from HC Wainwright - MarketBeat
Dianthus Therapeutics (NASDAQ:DNTH) Announces Quarterly Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat
2.10%
1.57%
자본화:
|
볼륨(24시간):